{"id":"W2007340026","doi":"10.1177/1756283x08092548","title":"Review: Efficacy and safety of adalimumab in Crohn's disease","year":2008,"lang":"en","type":"article","venue":"Therapeutic Advances in Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":33,"is_retracted":false,"has_abstract":true,"ca_institutions":"Foothills Medical Centre; University of Calgary","funders":"","keywords":"Medicine; Adalimumab; Infliximab; Concomitant; Crohn's disease; Placebo; Internal medicine; Monoclonal antibody; Gastroenterology; Immunogenicity; Population; Tumor necrosis factor alpha; Antibody; Surgery; Disease; Immunology; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001435342,0.0008590671,0.004255761,0.002780975,0.0003450956,0.001875412,0.00159681,0.001750608,0.007994458],"category_scores_gemma":[0.004791935,0.0003878102,0.001337288,0.003898519,0.0005161485,0.001256558,0.0006967384,0.001422018,0.001587954],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.000994666,"about_ca_system_score_gemma":0.001901636,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001473846,"about_ca_topic_score_gemma":0.002356119,"domain_scores_codex":[0.9990922,0.0002194483,0.0003082075,0.000090199,0.0002577303,0.00003215737],"domain_scores_gemma":[0.9963892,0.002216921,0.000727553,0.00004643592,0.0005058295,0.0001140976],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"systematic_review","study_design_scores_codex":[0.0004176798,0.00003709943,0.0002084229,0.4196525,0.0009917223,0.0001494024,0.00009156506,0.0001308106,0.0003685289,0.0007376379,0.07667804,0.5005366],"study_design_scores_gemma":[0.0003550656,0.0004162947,0.003849714,0.2912853,0.006103898,0.001655056,0.0001869181,0.0001419028,0.0003223814,0.001061489,0.6945682,0.00005394269],"study_design_candidate":"systematic_review","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00008199684,0.9987885,0.00002417266,0.0002583983,0.0004056903,0.00001315811,0.00005728518,0.000004617826,0.0003660869],"genre_scores_gemma":[0.00109316,0.9974614,0.00006690434,0.0005735657,0.0004694184,0.00001954275,0.00008234994,0.000002634557,0.0002310339],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.007994458,"threshold_uncertainty_score":0.02674407,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008379344914020771,"score_gpt":0.2645594977694259,"score_spread":0.2561801528554052,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}